<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00628448121998</udiDi>
    <basicUdiDi>B-00628448121998</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>Carcinoembryonic Antigen (CEA) Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0194-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:35.630Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448122001</udiDi>
    <basicUdiDi>B-00628448122001</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>Epithelial Membrane Antigen (EMA) Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0236-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:34.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121981</udiDi>
    <basicUdiDi>B-00628448121981</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>HCG-beta Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0201-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:20.367Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121974</udiDi>
    <basicUdiDi>B-00628448121974</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>Chromogranin A (CgA) Recombinant Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0202-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:18.773Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121967</udiDi>
    <basicUdiDi>B-00628448121967</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>Desmin Recombinant Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0231-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:16.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121950</udiDi>
    <basicUdiDi>B-00628448121950</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>c-erbB-2/HER2 Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0196-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:14.773Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121943</udiDi>
    <basicUdiDi>B-00628448121943</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD99 Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0175-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:13.965Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121936</udiDi>
    <basicUdiDi>B-00628448121936</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD117/c-kit Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0184-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:12.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121929</udiDi>
    <basicUdiDi>B-00628448121929</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD79a Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0165-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:09.960Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121912</udiDi>
    <basicUdiDi>B-00628448121912</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD56 Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0148-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:08.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121905</udiDi>
    <basicUdiDi>B-00628448121905</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD68 Recombinant Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0160-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:07.565Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121899</udiDi>
    <basicUdiDi>B-00628448121899</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD43 Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0126-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:05.957Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121882</udiDi>
    <basicUdiDi>B-00628448121882</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD31 Recombinant Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0114-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:03.570Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121875</udiDi>
    <basicUdiDi>B-00628448121875</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD45/LCA Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0131-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:01.949Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121868</udiDi>
    <basicUdiDi>B-00628448121868</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD34 Mouse Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0117-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:30:01.156Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121851</udiDi>
    <basicUdiDi>B-00628448121851</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD38 Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0122-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:29:59.580Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121844</udiDi>
    <basicUdiDi>B-00628448121844</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD30/Ki-1 Recombinant Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0113-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:29:57.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121837</udiDi>
    <basicUdiDi>B-00628448121837</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD23 Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0104-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:29:55.549Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121820</udiDi>
    <basicUdiDi>B-00628448121820</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD19 Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0099-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:29:54.752Z</lastUpdated>
  </row>
  <row>
    <udiDi>00628448121813</udiDi>
    <basicUdiDi>B-00628448121813</basicUdiDi>
    <tradeName>Labex Canada</tradeName>
    <deviceName>CD21 Recombinant Rabbit Monoclonal Antibody</deviceName>
    <manufacturerName>Labex Canada Inc.</manufacturerName>
    <manufacturerSrn>CA-MF-000039965</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030709</emdnCode>
    <emdnDescription>PRIMARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LCM-0101-1.0</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-04T14:29:53.152Z</lastUpdated>
  </row>
</eudamedExport>